Printed From BioPortfolio.com
'Really Durable Benefit' Emerging With Bladder Cancer ImmunoTx
03:13 EST 16 Feb 2018 | Medscape
Overall survival curves in cancer treatment trials typically go down with time. It's a big deal when survival stabilizes and a flat 'tail' emerges as patients remain alive much longer.
Medscape Medical News
Original Article: 'Really Durable Benefit' Emerging With Bladder Cancer ImmunoTx
